Core Viewpoint - WuXi AppTec's stock prices surged, with A-shares rising nearly 8% to 106.5 yuan and H-shares increasing nearly 10% to 121.5 HKD, reaching new highs since October of the previous year, following the announcement of expected revenue and profit growth for 2025 [1] Financial Performance - The company anticipates achieving operating revenue of 45.456 billion yuan in 2025, representing a year-on-year increase of 15.84% [1] - Adjusted net profit attributable to shareholders is projected to be 14.957 billion yuan, reflecting a year-on-year growth of 41.33% [1] - Net profit attributable to shareholders is expected to reach 19.151 billion yuan, marking a significant year-on-year increase of 102.65% [1] Business Strategy - The anticipated performance improvement is primarily attributed to the company's focus on its unique "integrated, end-to-end" CRDMO business model [1] - Additional revenue is expected from the sale of stakes in joint ventures and the divestiture of certain business segments, contributing to investment gains [1]
港A异动丨药明康德AH股齐涨创去年10月以来新高,2025年净利预增102.65%